Farmakoterapia w Psychiatrii i Neurologii

Abstract

2/2025 vol. 41
Case report

Potentiation of antidepressant treatment with racemic ketamine in a patient with an episode of severe depression in the course of bipolar disorder (BD) and a positive history of psychotic mania – a case report

  1. Department of Adult Psychiatry, Medical University of Lodz, Poland; Klinika Psychiatrii Dorosłych Uniwersytetu Medycznego w Łodzi, Łodź, Polska
Farmakoterapia w Psychiatrii i Neurologii 2025
Online publish date: 2026/04/28
View full text

Objectives

Although ketamine has become standard treatment for unipolar depression, particularly drug-resistant depression, its use for bipolar depression requires careful consideration of potential benefits and risks, especially in patients with a history of psychotic symptoms.

Case report

In a 52-year-old man with BD, the depressive episode was severe and showed no satisfactory improvement despite multiple changes to pharmacotherapy; therefore, augmentation with intravenous racemic ketamine was considered. However, concern was raised because the patient had experienced a severe manic episode with psychotic features seven years earlier. The patient received racemic ketamine.

Conclusions

A prior history of manic episodes or psychotic symptoms in BD should not automatically preclude ketamine treatment; however, a detailed, individualised risk assessment is essential in each case.

Share
without publication fees
without publication fees